These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

792 related items for PubMed ID: 27184361

  • 41. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma.
    Tanvetyanon T, Qin D, Padhya T, McCaffrey J, Zhu W, Boulware D, DeConti R, Trotti A.
    Arch Otolaryngol Head Neck Surg; 2009 Jul; 135(7):687-92. PubMed ID: 19620591
    [Abstract] [Full Text] [Related]

  • 42. Management and outcome of salivary duct carcinoma in major salivary glands.
    Salovaara E, Hakala O, Bäck L, Koivunen P, Saarilahti K, Passador-Santos F, Leivo I, Mäkitie AA.
    Eur Arch Otorhinolaryngol; 2013 Jan; 270(1):281-5. PubMed ID: 22437251
    [Abstract] [Full Text] [Related]

  • 43. A Case of Salivary Duct Carcinoma Intracranial Invasion due to Perineural Invasion Through the Facial Nerve.
    Enomoto T, Aoki M, Miyagawa K, Matsumoto J, Kobayashi H, Takeuchi T, Abe H, Nonaka M, Sakata T, Inoue T, Nabeshima K.
    World Neurosurg; 2020 Aug; 140():332-337. PubMed ID: 32473330
    [Abstract] [Full Text] [Related]

  • 44. Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review.
    Uijen MJM, Lassche G, van Engen-van Grunsven ACH, Tada Y, Verhaegh GW, Schalken JA, Driessen CML, van Herpen CML.
    Cancer Treat Rev; 2020 Sep; 89():102069. PubMed ID: 32717621
    [Abstract] [Full Text] [Related]

  • 45. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
    Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A.
    Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
    [Abstract] [Full Text] [Related]

  • 46. Prognostic factors in postoperative radiotherapy in salivary gland carcinoma: A single institution experience from Turkey.
    Kandaz M, Soydemir G, Bahat Z, Canyılmaz E, Yöney A.
    Indian J Cancer; 2016 Nov; 53(2):274-279. PubMed ID: 28071626
    [Abstract] [Full Text] [Related]

  • 47. Radiation therapy for patients of malignant salivary gland tumors with positive surgical margins.
    Sakata K, Aoki Y, Karasawa K, Nakagawa K, Hasezawa K, Muta N, Terahara A, Onogi Y, Sasaki Y, Akanuma A.
    Strahlenther Onkol; 1994 Jun; 170(6):342-6. PubMed ID: 8023243
    [Abstract] [Full Text] [Related]

  • 48. Intraoral salivary duct carcinoma: a clinicopathological study of four cases and review of the literature.
    Epivatianos A, Dimitrakopoulos J, Trigonidis G.
    Ann Dent; 1995 Jun; 54(1-2):36-40. PubMed ID: 8572543
    [Abstract] [Full Text] [Related]

  • 49. Salivary duct carcinoma: clinical characteristics and treatment strategies.
    Guzzo M, Di Palma S, Grandi C, Molinari R.
    Head Neck; 1997 Mar; 19(2):126-33. PubMed ID: 9059870
    [Abstract] [Full Text] [Related]

  • 50. Gamma knife stereotactic radiosurgery for salivary gland neoplasms with base of skull invasion following neutron radiotherapy.
    Douglas JG, Goodkin R, Laramore GE.
    Head Neck; 2008 Apr; 30(4):492-6. PubMed ID: 18023034
    [Abstract] [Full Text] [Related]

  • 51. Prognostic factors and outcome analysis of salivary duct carcinoma.
    Han MW, Roh JL, Choi SH, Nam SY, Lee HJ, Cho KJ, Lee SW, Kim SY.
    Auris Nasus Larynx; 2015 Dec; 42(6):472-7. PubMed ID: 26028371
    [Abstract] [Full Text] [Related]

  • 52. Salivary duct carcinoma of the parotid gland: is adjuvant HER-2-targeted therapy required?
    Lee JS, Kwon OJ, Park JJ, Seo JH.
    J Oral Maxillofac Surg; 2014 May; 72(5):1023-31. PubMed ID: 24480767
    [Abstract] [Full Text] [Related]

  • 53. Salivary duct carcinoma.
    D'heygere E, Meulemans J, Vander Poorten V.
    Curr Opin Otolaryngol Head Neck Surg; 2018 Apr; 26(2):142-151. PubMed ID: 29373327
    [Abstract] [Full Text] [Related]

  • 54. Hybrid carcinoma of the parotid gland: report of a case (epithelial-myoepithelial carcinoma and salivary duct carcinoma) and review of the literature.
    Kainuma K, Oshima A, Suzuki H, Fukushima M, Shimojo H, Usami S.
    Acta Otolaryngol; 2010 Apr; 130(1):185-9. PubMed ID: 19449226
    [Abstract] [Full Text] [Related]

  • 55. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma.
    Griffith CC, Thompson LD, Assaad A, Purgina BM, Lai C, Bauman JE, Weinreb I, Seethala RR, Chiosea SI.
    Histopathology; 2014 Dec; 65(6):854-60. PubMed ID: 24804831
    [Abstract] [Full Text] [Related]

  • 56. Management of nasopharyngeal salivary gland malignancy.
    Schramm VL, Imola MJ.
    Laryngoscope; 2001 Sep; 111(9):1533-44. PubMed ID: 11568602
    [Abstract] [Full Text] [Related]

  • 57. The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center.
    Mayer M, Wolber P, Prinz J, Jansen L, Esser J, Shabli S, Quaas A, Klußmann JP, Sharma SJ, Nachtsheim L, Arolt C.
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3779-3789. PubMed ID: 38587651
    [Abstract] [Full Text] [Related]

  • 58. Salivary duct carcinoma of the accessory parotid gland.
    Funamura JL, Aouad RK, Ramsamooj R, Donald PJ.
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):347-8. PubMed ID: 23652666
    [No Abstract] [Full Text] [Related]

  • 59. [Our results of postoperative radiation therapy in patients with salivary gland cancer].
    Demiroz Abakay C, Şahintürk K, Türk A, Özkan L, Özmen A.
    Kulak Burun Bogaz Ihtis Derg; 2014 Aug; 24(6):316-23. PubMed ID: 25547744
    [Abstract] [Full Text] [Related]

  • 60. [Clinicopathological study of salivary duct carcinoma].
    Shimizu A, Yamane M, Ito H, Araki S, Yoshida T, Suzuki M.
    Nihon Jibiinkoka Gakkai Kaiho; 2002 Jun; 105(6):727-31. PubMed ID: 12138700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.